Enanta Pharmaceuticals | Modal Dan Cadangan





Modal Dan Cadangan Perubahan Tanggal
AbbVie USD -3.27B 628M 2025-12
Amgen USD 8.66B 961M 2025-12
Anika Therapeutics USD 146.8M 867K 2025-09
Arrowhead Research USD 568.42M 102.37M 2025-12
AstraZeneca USD 48.67B 2.78B 2025-12
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
Biogen USD 18.21B 573.5M 2025-09
Bristol-Myers Squibb USD 18.55B 1.06B 2025-09
Enanta Pharmaceuticals USD 126.59M 61.87M 2025-12
Gilead Sciences USD 22.62B 1.16B 2025-12
GlaxoSmithKline GBP 16.38B 229M 2025-12
Halozyme Therapeutics USD 48.81M 455.1M 2025-12
Heron Therapeutics USD 14.88M 42.14M 2025-09
Immunic USD 10.5M 23.41M 2025-09
Incyte USD 5.17B 516.28M 2025-12
Insmed USD 738.98M 206.6M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
J&J USD 78.47B 0 2025-09
Karyopharm Therapeutics USD -269.26M 30.33M 2025-09
Ligand Pharmaceuticals USD 1.02B 67.04M 2025-12
Merck USD 51.85B 2.79B 2025-09
Neurocrine Biosciences USD 3.25B 249.5M 2025-12
Novartis USD 44.75B 2.7B 2025-09
Novavax USD -156.67M 194.3M 2025-09
Pfizer USD 92.8B 4.11B 2025-09
PTC Therapeutics USD -205.31M 49.56M 2025-12
Roche Holding CHF 33.8B 758M 2025-12
Sarepta Therapeutics USD 1.14B 179.5M 2025-12
Vertex Pharmaceuticals USD 18.67B 1.35B 2025-12


Enanta Pharmaceuticals Modal Dan Cadangan - Nilai saat ini, data historis, perkiraan, statistik, grafik dan kalender ekonomi - Mar 2026.